<?xml version="1.0" encoding="UTF-8"?>
<p>PTLD emerges as either of recipient or donor origin depending on the type of transplant. Bone marrow transplant (BMT) patients develop PTLD of donor origin when EBV-infected B cells derived from the donor marrow proliferate into lymphoma. Conversely, solid organ transplant patients develop PTLD of recipient origin when EBV released from the transplanted organ infects the recipientâ€™s B cells [
 <xref ref-type="bibr" rid="CR4">4</xref>, 
 <xref ref-type="bibr" rid="CR39">39</xref>].
</p>
